Axsome Therapeutics (NASDAQ: AXSM) announced it has entered into an asset purchase agreement to acquire exclusive global rights to balipodect ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE